Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, May 12, 2015 12:50:40 PM
bullish
recent big move
http://finance.yahoo.com/news/fate-therapeutics-fate-catches-eye-134601769.html
## source: finance.yahoo.com
Thu, 07 May 2015 21:13:16 GMT ~ Fate Therapeutics reports 1Q loss
read full: http://sg.finance.yahoo.com/news/fate-therapeutics-reports-1q-loss-211316882.html
*********************************************************
Thu, 07 May 2015 21:13:16 GMT ~ Fate Therapeutics reports 1Q loss
read full: http://finance.yahoo.com/news/fate-therapeutics-reports-1q-loss-211316428.html
*********************************************************
Thu, 07 May 2015 21:00:00 GMT ~ Fate Therapeutics Inc Earnings Call scheduled for 5:00 pm ET today
read full: http://biz.yahoo.com/cc/0/150320.html
*********************************************************
Thu, 07 May 2015 20:02:45 GMT ~ FATE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
read full: http://biz.yahoo.com/e/150507/fate8-k.html
*********************************************************
Thu, 07 May 2015 20:01:00 GMT ~ Fate Therapeutics Reports First Quarter 2015 Financial Results
[GlobeNewswire] - Strategic Research Collaboration Established with Juno Therapeutics to Apply Small Molecule Modulators for Programming CAR and TCR Immunotherapies
read full: http://finance.yahoo.com/news/fate-therapeutics-reports-first-quarter-200100506.html
*********************************************************
$FATE charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$FATE company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/FATE/company-info
Ticker: $FATE
OTC Market Place: Not Available
CIK code: not found
Company name: Fate Therapeutics, Inc.
Incorporated In:
Business Description:
$FATE share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$FATE extra dd links
Company name: Fate Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FATE/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FATE/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FATE+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FATE+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FATE+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FATE/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FATE/news - http://finance.yahoo.com/q/h?s=FATE+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FATE/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FATE/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FATE/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FATE/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FATE/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FATE/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FATE/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FATE/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FATE+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FATE
DTCC (dtcc.com): http://search2.dtcc.com/?q=Fate+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Fate+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Fate+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FATE/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FATE
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FATE/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FATE/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FATE/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FATE/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FATE/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FATE/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FATE/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FATE&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FATE
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FATE/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FATE+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FATE+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FATE
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FATE
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FATE+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FATE/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FATE+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FATE.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FATE
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FATE/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FATE/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FATE/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FATE/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FATE
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FATE
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FATE:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FATE
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FATE
$FATE DD Notes ~ http://www.ddnotesmaker.com/FATE
Recent FATE News
- Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting • GlobeNewswire Inc. • 05/03/2024 08:30:00 PM
- Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting • GlobeNewswire Inc. • 04/22/2024 08:30:00 PM
- Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/02/2024 08:01:00 PM
- Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement • GlobeNewswire Inc. • 03/19/2024 12:44:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:24:31 PM
- Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 06:29:13 PM
- Fate Therapeutics to Present at Upcoming March Investor Conferences • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 09:10:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:03:08 PM
- Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 02/26/2024 09:01:00 PM
- Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 11:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:09:29 PM
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:01:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/29/2024 06:44:15 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/25/2024 09:19:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:30:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:30:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:29:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM